Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Enochian Biosciences, Inc.

Enochian Biosciences, Inc. (ENOB) Stock Overview

Explore Enochian Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ENOB●NASDAQ
HealthcareBiotechnology
$0.71
$0.01(1.79%)
U.S. Market is Open · 13:07

Enochian Biosciences, Inc. (ENOB)

Meyka AI Score

Z

Key Financials

Market Cap45.4M
P/E Ratio-0.88
EPS (TTM)$-2.07
ROE8.93%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ENOB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Enochian Biosciences, Inc. (NASDAQ: ENOB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Enochian Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ENOB on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Enochian Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.88 and a market capitalization of 45.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ENOB on the NASDAQ.

Price Performance (NASDAQ: ENOB)

1-Day Change
N/A
5-Day Change
-70.44%
1-Month Change
1.79%
3-Month Change
-13.11%
6-Month Change
-38.04%
Year-to-Date (YTD) Change
-36.38%
1-Year Change
-66.86%
3-Year Change
-81.78%
5-Year Change
-85.49%
All-Time (Max) Change
-88.13%

Contact Information

https://www.enochianbio.com
305 918 1980
Century City Medical Plaza, Los Angeles, CA, 90067-2012

Company Facts

220 Employees
IPO DateFeb 7, 2018
CountryUS

Frequently Asked Questions